Events

Alcohol use disorder is a common chronic condition. Although multiple pharmacotherapies have been shown to reduce drinking in people with this disorder, these important treatment strategies are underutilized. Dr. Mary Brunette will provide an overview of how to conduct assessments and provide evidence-based pharmacologic management for people with alcohol use disorders in primary and specialty care settings.

Dr. Mary F. Brunette is an Associate Professor of Psychiatry at Geisel School of Medicine at Dartmouth and the Medical Director of the Bureau of Mental Health Services within the New Hampshire Department of Health and Human Services. As a board-certified addiction psychiatrist, she has been involved with research and clinical care of patients with mental illnesses and co-occurring substance use disorders for over 20 years. She has been active with both psychosocial research and clinical trials studying treatments for people with these co-occurring disorders and other disadvantaged populations. In the past few years, she initiated a program of research on smoking cessation for people with mental illnesses, and has been involved in studying the use of technology to increase the efficacy and expand the research of treatments for people with co-occurring disorders, with a focus on people with severe mental illnesses in general and nicotine addiction in particular.

This installment of the Northeast Node’s Science Series will be available via BlueJeans.com at https://bluejeans.com/191888382 (We recommend that you visit BlueJeans.com prior to the presentation so that you can download the BlueJeans client/app).

This presentation will also be recorded and archived on our website, www.ctnnortheastnode.org, alongside previous Science Series presentations.

We are anticipating a large number of attendees at this session, so please be sure to let us know if you plan to attend in person.